The effect of insulin degludec in combination with liraglutide and metformin in patients with type 2 diabetes requiring treatment intensification

被引:0
作者
Aroda, V. R. [1 ]
Bailey, T. [2 ]
Cariou, B. [3 ]
Kumar, S. [4 ,5 ]
Leiter, L. A. [6 ]
Raskin, P. [7 ]
Zacho, J. [8 ]
Bandier, M. [8 ]
Philis-Tsimikas, A. [9 ]
机构
[1] MedStar Hlth Res Inst, Hyattsville, MD USA
[2] AMCR Inst Inc, Escondido, CA USA
[3] Nantes Univ Hosp, Dept Endocrinol, Nantes, France
[4] Univ Hosp Coventry, WISDEM Ctr, Coventry, W Midlands, England
[5] Univ Hosp Warwickshire, WISDEM Ctr, Coventry, W Midlands, England
[6] Univ Toronto, St Michaels Hosp, Toronto, ON M5S 1A1, Canada
[7] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[8] Novo Nordisk AS, Soborg, Denmark
[9] Scripps Whittier Diabet Inst, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
145
引用
收藏
页码:S68 / S68
页数:1
相关论文
共 50 条
[31]   Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide [J].
Vedtofte, Louise ;
Knop, Filip K. ;
Vilsboll, Tina .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (03) :273-282
[32]   Liraglutide add-on to insulin degludec plus metformin vs addition of a single dose of insulin aspart to the largest meal in patients with Type 2 diabetes [J].
Russell-Jones, D. ;
Mathieu, C. ;
Rodbard, H. W. ;
Cariou, B. ;
Handelsman, Y. ;
Philis-Tsimikas, A. ;
Francisco, A. M. Ocampo ;
Rana, A. ;
Zinman, B. .
DIABETIC MEDICINE, 2014, 31 :52-52
[33]   Switching from Sitagliptin to Liraglutide, in Combination with Metformin, Improves Treatment Satisfaction in Patients with Type 2 Diabetes [J].
Montanya, Eduard ;
Pratley, Richard ;
Nauck, Michael ;
Bailey, Timothy ;
Garber, Alan ;
Filetti, Sebastiano ;
Thomsen, Anne B. ;
Hammer, Mette ;
Davies, Melanie .
DIABETES, 2011, 60 :A307-A307
[34]   HDL LIPIDOMIC ANALYSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS RECEIVING FIXED-DOSE COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE [J].
Pappa, E. ;
Vavli, E. ;
Kostara, C. ;
Bairaktari, E. ;
Tsimihodimos, V. .
ATHEROSCLEROSIS, 2020, 315 :E65-E65
[35]   IDegLira, a combination of insulin degludec and liraglutide, improves both pre- and postprandial plasma glucose in patients with type 2 diabetes [J].
King, A. ;
Philis-Tsimikas, A. ;
Langbakke, I. H. ;
Kvist, K. ;
Vilsboll, T. .
DIABETOLOGIA, 2014, 57 :S108-S109
[36]   Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes [J].
Rodbard, H. W. ;
Buse, J. B. ;
Woo, V. ;
Vilsboll, T. ;
Langbakke, I. H. ;
Kvist, K. ;
Gough, S. C. L. .
DIABETES OBESITY & METABOLISM, 2016, 18 (01) :40-48
[37]   Novel combination of insulin degludec and liraglutide (IDegLira) is efficacious across the range of disease progression in type 2 diabetes [J].
Rodbard, H. W. ;
Buse, J. B. ;
Woo, V. C. ;
Vilsboll, T. ;
Langbakke, I. ;
Korsholm, L. ;
Gough, S. .
DIABETOLOGIA, 2014, 57 :S338-S339
[38]   Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes [J].
Lingvay, Ildiko ;
Raskin, Philip ;
Szczepaniak, Lidia S. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) :137-142
[39]   Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin [J].
Vilsboll, Tina ;
Blevins, Thomas C. ;
Jodar, Esteban ;
Poulter, Neil ;
Tentolouris, Nikolaos ;
Agner, Bue F. Ross ;
Lehmann, Lucine ;
Leiter, Lawrence A. .
DIABETES OBESITY & METABOLISM, 2019, 21 (06) :1506-1512
[40]   Superior efficacy with a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin-naive Japanese patients with type 2 diabetes in a phase 3, open-label, randomized trial [J].
Kaku, Kohei ;
Araki, Eiichi ;
Tanizawa, Yukio ;
Agner, Bue Ross ;
Nishida, Tomoyuki ;
Ranthe, Mattis ;
Inagaki, Nobuya .
DIABETES OBESITY & METABOLISM, 2019, 21 (12) :2674-2683